Etamicastat

DB15288InvestigationalSmall molecule

Etamicastat is under investigation in clinical trial NCT02840565 (Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453).

Formula / weight: C₁₄H₁₅F₂N₃OS · 311.35 g/mol (avg)

Resolves to

Compound

UNII9X96V6DBU4CAS760173-05-5ChEMBLCHEMBL1196088

Structure

InChIKeyCWWWTTYMUOYSQA-LLVKDONJSA-NSMILESNCCC1=CNC(=S)N1[C@H]1COC2=C(C1)C=C(F)C=C2F

Targets

P09172DBH

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Etamicastat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account